Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-01 Purchase | 2021-12-10 6:50 pm | Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner | 185,941 | $1.66 | $308,662 | 0 (Indirect) | View |
| 2021-12-01 Sale | 2021-12-10 6:50 pm | Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner | 5,887,610 | $1.6545 | $9,741,063 | 0 (Indirect) | View |
| 2021-11-22 Sale | 2021-11-24 6:00 pm | Odonate Therapeutics Inc. | ODT | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH 10% Owner | 400,000 | $1.5583 | $623,340 | 4,207,086 (Direct) | View |
| 2021-11-17 Sale | 2021-11-19 7:22 pm | Odonate Therapeutics Inc. | ODT | Davis Aaron I. Director 10% Owner | 1,200,000 | $2.0833 | $2,499,948 | 5,052,842 (Indirect Direct) | View |
| 2021-11-17 Sale | 2021-11-19 7:21 pm | Odonate Therapeutics Inc. | ODT | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Director 10% Owner | 1,000,000 | $2.0628 | $2,062,775 | 4,607,086 (Direct) | View |
| 2021-11-17 Sale | 2021-11-19 4:38 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Chief Executive Officer 10% Owner | 2,747,131 | $2.086 | $5,730,557 | 12,767,435 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2021-11-18 1:00 pm | N/A N/A | Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner | 0 | $0 | 5,701,669 (Indirect) | View |
| 2021-03-15 Option Award | 2021-03-17 4:04 pm | N/A 2031-03-15 | Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer | 37 | $0 | 15,517,223 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 4:04 pm | N/A N/A | Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer | 37 | $16.22 | 15,517,223 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 4:04 pm | N/A 2031-03-15 | Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer | 99 | $0 | 3,709 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 4:04 pm | N/A N/A | Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer | 99 | $16.22 | 3,709 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:03 pm | N/A 2031-02-26 | Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer | 34 | $0 | 15,517,183 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:03 pm | N/A N/A | Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer | 34 | $17.89 | 15,517,183 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:02 pm | N/A 2031-02-26 | Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer | 90 | $0 | 3,601 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:02 pm | N/A N/A | Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer | 90 | $17.89 | 3,601 (Direct) | View |